Products
Platform
Research
Market
Learn
Compare DSP Nifty Healthcare Index Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 0.94 | 1.87 |
NAV | ₹10.40 | ₹40.36 |
Fund Started | 02 Jun 2025 | 25 Jun 2018 |
Fund Size | ₹12.93 Cr | ₹6226.82 Cr |
Exit Load | - | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
0.94
1.87
NAV
₹10.40
₹40.36
Fund Started
02 Jun 2025
25 Jun 2018
Fund Size
₹12.93 Cr
₹6226.82 Cr
Exit Load
-
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | - | 4.56% |
3 Year | - | 27.00% |
5 Year | - | 20.85% |
1 Year
-
4.56%
3 Year
-
27.00%
5 Year
-
20.85%
Holding Analysis
Equity | 99.32% | 97.55% |
Cash | 0.68% | 2.45% |
Equity
99.32%
97.55%
Cash
0.68%
2.45%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 17.67% |
Cipla Ltd. | 8.89% |
Max Healthcare Institute Ltd. | 8.71% |
Apollo Hospitals Enterprise Ltd. | 7.87% |
Dr. Reddy's Laboratories Ltd. | 7.84% |
Divi's Laboratories Ltd. | 7.60% |
Fortis Healthcare Ltd. | 5.31% |
Lupin Ltd. | 4.86% |
Torrent Pharmaceuticals Ltd. | 3.96% |
Laurus Labs Ltd. | 3.44% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.58% |
Dr. Reddy's Laboratories Ltd. | 9.10% |
Divi's Laboratories Ltd. | 8.75% |
Aurobindo Pharma Ltd. | 8.25% |
Cipla Ltd. | 6.92% |
Lupin Ltd. | 5.43% |
Alkem Laboratories Ltd. | 4.05% |
Biocon Ltd. | 3.11% |
Gland Pharma Ltd. | 2.97% |
Mankind Pharma Ltd. | 2.95% |
Fund Manager
Name | Anil Ghelani | Dharmesh Kakkad |
Start Date | 08 Aug 2025 | 23 Feb 2021 |
Name
Anil Ghelani
Dharmesh Kakkad
Start Date
08 Aug 2025
23 Feb 2021
About Fund
Description | The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 02 Jun 2025 | 25 Jun 2018 |
Description
The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
02 Jun 2025
25 Jun 2018